The dementia drug rivastigmine may reduce the risk of falls in patients with Parkinson’s disease by improving gait stability, findings from the phase II ReSponD trial show.
from Dementia Big http://ift.tt/1JWQVCh
via Stopping Dementia
from WordPress http://ift.tt/1PEgCE6
via alcoholic dementia
http://ift.tt/1Pg6sPR
No comments:
Post a Comment